Kordova aims to improve patient care by making life easier for their health care provider.
A medical technology company started in Boston, Ma., in 2016, Kordova operates a platform that tracks implant devices used in surgery. They gather information on a website to help physicians and hospital executives find the most efficient and cost-effective device for the patient.
“On our side, we’re pulling data from the FDA and other sources and we can look at clinical studies for different devices,” said Kordova co-founder Matt Daniels. “We’re aggregating all the information together and organizing it.”
While information about devices was available before the emergence of a comprehensive platform like Kordova – the first of its kind that “seamlessly connects the surgeon, hospital, and implant vendor,” as written on its website – it was difficult to research. Information about the device’s previous uses, success or failure was often left out.
And it could be hard for doctors, co-founder Peter St. John explained, to find specific and critical details about devices while still performing usual tasks at a high level.
“It’s so hard to know,” St. John said of finding the correct implant devices for patients. “Now that physicians have all that information readily available, it’s extremely beneficial.”
Kordova is able to pull data using its own application, as well as from hospital records, and then put the findings through its analytics program and relay results to the doctor. The effort is meant to put responsibility back in the hands of the health care provider, in a seamless and efficient way.
Kordova has launched its pilot account and partnered with one of the largest healthcare systems in New England to continue to develop its software and market its capability to hospitals and physicians.
Over the next few years, St. John and Daniels said they hope to evolve Kordova’s platform and pull data from even more sources to help healthcare providers, ultimately for the best interest of the patients.
“Hopefully with our platform, patients end up receiving implants that are better suited for their specific needs, at a lower cost,” St. John said.
Zach is a graduate of the University of Tampa and a former Buccaneers beat writer. He's currently a journalism grad student at the University of Maryland and grateful for the opportunity to contribute to MedTech Boston. New to a personal Twitter account, find him @shapzach
Send this to a friend